Recent attempts to understand the biological bases of depression vulnerability have revealed that both the short allele of the serotonin transporter-linked polymorphic region (5-HTTLPR) and activity in the amygdala are associated with depression. Other studies have reported amygdala hyperactivity associated with the 5-HTTLPR short allele, linking the genetic and neuroimaging lines of research and suggesting a mechanism whereby the short allele confers depression risk. However, fewer investigations have examined the associations among depression, 5-HTTLPR variability, and amygdala activation in a single study. The current study thus investigated whether 5-HTTLPR genotype modulates the association between depressive symptoms and amygdala activity among psychiatrically healthy adults. Regional cerebral blood flow was measured with perfusion fMRI during a task-free scan. We hypothesized differential associations between depressive symptoms and amygdala activity among individuals homozygous for the short allele and individuals homozygous for the long allele. Both whole brain analyses and region-of-interest analyses confirmed this prediction, revealing a significant negative association among the long allele group and a trend of positive association among the short allele group. These results complement existing reports of short allele related amygdala hyperactivity and suggest an additional neurobiological mechanism whereby the 5-HTTLPR is associated with psychiatric outcomes.
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Introduction
Recent attempts to understand the biological bases of depression vulnerability have focused on both genetic and neural risk factors. One of the most commonly studied genetic polymorphisms is the serotonin transporter-linked polymorphic region (5-HTTLPR). The short (S) allele of the 5-HTTLPR is associated with several psychiatric conditions, perhaps most notably depression (e.g., Lotrich and Pollock, 2004) . Given its location in the promoter region upstream from the serotonin transporter gene, this polymorphism affects the efficiency of DNA transcription into messenger RNA; the S allele is associated with decreased transcription efficiency, which leads to less production of the serotonin transporter protein and subsequently to less reuptake of serotonin (Lesch et al., 1996) .
Part of the behavioral mechanism by which the 5-HTTLPR exerts its effects appears to be through conferring differential reactivity to stress. For example, Caspi et al. (2003) demonstrated that 5-HTTLPR genotype interacts with stressful life events to predict depression outcomes; other studies have reported similar effects (e.g., Kaufman et al., 2004; Kendler et al., 2005; however, see Risch et al., 2009 ). More recent studies have begun to identify the effects of this genetic variability on human behavior, physiology, and neural systems. Gotlib and colleagues, for example, identified effects of the 5-HTTLPR on cortisol levels, both at rest (Chen et al., 2009) and in response to stressors (Gotlib et al., 2008); in addition, Reimold et al. (2011) reported a significant interaction between 5-HTTLPR genotype and cortisol response on serotonin transporter binding potential in the human thalamus.
An intersecting line of depression vulnerability research has focused on activity in the amygdala. There is evidence that amygdala activity is elevated during depression (Drevets et al., 2002) and during experimentally induced negative affective states (Posse et al., 2003) . Other studies have shown that amygdala activity is positively associated with an improvement in depression symptoms, including in response to cognitive behavioral therapy (Siegle et al., 2006) . These and similar findings have led to the hypothesis that the amygdala is Psychiatry Research: Neuroimaging 193 (2011) 161-167 
